Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors

Source: MDLinx, September 2020

Given that melanoma is the third most common cancer in the adolescent and young adult (AYA) population, researchers conducted this investigation to analyze the occurrence of adverse health conditions following melanoma treatment in these survivors.

Data were gathered from the California Cancer Registry for patients aged 15 to 39 years diagnosed with cutaneous melanoma from 1996 to 2012 and surviving greater than or equal to 2 years and linked to statewide hospitalization data.

Using Cox proportional hazards regression models, the influence of age at diagnosis, sex, race/ethnicity, neighborhood socioeconomic status (SES), health insurance, and surgery on the development of adverse health conditions was evaluated.